Bowden DS - Search Results

1

Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.

Aitken CK, Tracy SL, Revill P, Bharadwaj M, Bowden DS, Winter RJ, Hellard ME. Aitken CK, et al. Among authors: bowden ds. J Clin Virol. 2008 Apr;41(4):293-6. doi: 10.1016/j.jcv.2007.12.007. Epub 2008 Feb 1. J Clin Virol. 2008. PMID: 18242125

2

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M. Aitken CK, et al. Among authors: bowden ds. Hepatology. 2008 Dec;48(6):1746-52. doi: 10.1002/hep.22534. Hepatology. 2008. PMID: 18844233

3

Molecular epidemiology of hepatitis C virus in a social network of injection drug users.

Aitken CK, McCaw RF, Bowden DS, Tracy SL, Kelsall JG, Higgs PG, Kerger MJ, Nguyen H, Crofts JN. Aitken CK, et al. Among authors: bowden ds. J Infect Dis. 2004 Nov 1;190(9):1586-95. doi: 10.1086/424678. Epub 2004 Sep 23. J Infect Dis. 2004. PMID: 15478062

4

Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.

Miles JJ, Thammanichanond D, Moneer S, Nivarthi UK, Kjer-Nielsen L, Tracy SL, Aitken CK, Brennan RM, Zeng W, Marquart L, Jackson D, Burrows SR, Bowden DS, Torresi J, Hellard M, Rossjohn J, McCluskey J, Bharadwaj M. Miles JJ, et al. Among authors: bowden ds. J Immunol. 2011 Jan 15;186(2):901-12. doi: 10.4049/jimmunol.1003167. Epub 2010 Dec 15. J Immunol. 2011. PMID: 21160049

5

An extensive antigenic footprint underpins immunodominant TCR adaptability against a hypervariable viral determinant.

Nivarthi UK, Gras S, Kjer-Nielsen L, Berry R, Lucet IS, Miles JJ, Tracy SL, Purcell AW, Bowden DS, Hellard M, Rossjohn J, McCluskey J, Bharadwaj M. Nivarthi UK, et al. Among authors: bowden ds. J Immunol. 2014 Dec 1;193(11):5402-13. doi: 10.4049/jimmunol.1401357. Epub 2014 Oct 29. J Immunol. 2014. PMID: 25355921

6

GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.

Berzsenyi MD, Bowden DS, Roberts SK, Revill PA. Berzsenyi MD, et al. Among authors: bowden ds. J Gastroenterol Hepatol. 2009 Aug;24(8):1407-10. doi: 10.1111/j.1440-1746.2009.05920.x. J Gastroenterol Hepatol. 2009. PMID: 19702909

7

A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009.

Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, Antoniou M, Fullerton KE, Knope K, Copland JG, Bowden DS, Tracy SL, Hogg GG, Tan A, Adamopoulos J, Gaston J, Vally H. Donnan EJ, et al. Among authors: bowden ds. Clin Infect Dis. 2012 Mar;54(6):775-81. doi: 10.1093/cid/cir949. Epub 2012 Jan 11. Clin Infect Dis. 2012. PMID: 22238166

8

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.

Aitken CK, Agius PA, Higgs PG, Stoové MA, Bowden DS, Dietze PM. Aitken CK, et al. Among authors: bowden ds. Epidemiol Infect. 2017 Mar;145(4):796-801. doi: 10.1017/S0950268816002892. Epub 2016 Dec 8. Epidemiol Infect. 2017. PMID: 27927256 Free PMC article.

9

GB virus C: insights into co-infection.

Berzsenyi MD, Bowden DS, Roberts SK. Berzsenyi MD, et al. Among authors: bowden ds. J Clin Virol. 2005 Aug;33(4):257-66. doi: 10.1016/j.jcv.2005.04.002. J Clin Virol. 2005. PMID: 15922655 Review.

10

Male to male sex is associated with a high prevalence of exposure to GB virus C.

Berzsenyi MD, Bowden DS, Bailey MJ, White C, Coghlan P, Dudley FJ, Roberts SK. Berzsenyi MD, et al. Among authors: bowden ds. J Clin Virol. 2005 Jul;33(3):243-6. doi: 10.1016/j.jcv.2005.01.002. J Clin Virol. 2005. PMID: 15911447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page